Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124848692 | 12484869 | 2 | F | 20160529 | 20160705 | 20160621 | 20160720 | PER | US-ELI_LILLY_AND_COMPANY-US201606004439 | ELI LILLY AND CO | 83.00 | YR | F | Y | 0.00000 | 20160720 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124848692 | 12484869 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | 20 MG, BID | U | U | 21368 | 20 | MG | TABLET | BID | ||||
124848692 | 12484869 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | 40 MG, QD | U | U | 21368 | 40 | MG | TABLET | QD | ||||
124848692 | 12484869 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | CAPSULE | |||||||
124848692 | 12484869 | 4 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 0 | 5 | MG | QD | |||||||
124848692 | 12484869 | 5 | SS | BUPROPION. | BUPROPION | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 6 | SS | DIGOXIN. | DIGOXIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 7 | SS | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 8 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 9 | SS | LASIX | FUROSEMIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 10 | SS | ATIVAN | LORAZEPAM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
124848692 | 12484869 | 11 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 0 | ||||||||||||
124848692 | 12484869 | 12 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
124848692 | 12484869 | 13 | C | OCUVITE | VITAMINS | 1 | 0 | ||||||||||||
124848692 | 12484869 | 14 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124848692 | 12484869 | 1 | Pulmonary hypertension |
124848692 | 12484869 | 3 | Product used for unknown indication |
124848692 | 12484869 | 4 | Pulmonary arterial hypertension |
124848692 | 12484869 | 5 | Product used for unknown indication |
124848692 | 12484869 | 6 | Product used for unknown indication |
124848692 | 12484869 | 7 | Product used for unknown indication |
124848692 | 12484869 | 8 | Product used for unknown indication |
124848692 | 12484869 | 9 | Product used for unknown indication |
124848692 | 12484869 | 10 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124848692 | 12484869 | Fall | |
124848692 | 12484869 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124848692 | 12484869 | 1 | 201106 | 0 | ||
124848692 | 12484869 | 2 | 20110616 | 0 | ||
124848692 | 12484869 | 4 | 20150709 | 0 |